Izilendustat T001-00000002
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-carboxylate inhibit of human recombinant EGLN-1 as substrate after 20 mins by mass spectrophotometric analysis.
CAS nr:
1303512-02-8
Purity:
98%
Molecular Weight:
SMILES:
Formula:
Pathway:
Metabolism,Chromatin/Epigenetic
Target:
HIF/HIF Prolyl-Hydroxylase,HIF/HIF Prolyl-Hydroxylase
